These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9552949)

  • 61. Lipid lowering in patients 75 years and older.
    Makhmudova U; Schulze PC; Davis HR; Weingärtner O
    World J Cardiol; 2021 Oct; 13(10):526-532. PubMed ID: 34754397
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Saturated fatty acids and cardiovascular risk : Is a revision of the recommendations on nutrition indicated?].
    Worm N; Weingärtner O; Schulze C; Lechner K
    Herz; 2022 Aug; 47(4):354-365. PubMed ID: 34554285
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Markers of cholesterol synthesis to cholesterol absorption across the spectrum of non-dialysis CKD: An observational study.
    Emrich IE; Heine GH; Schulze PC; Rogacev KS; Fliser D; Wagenpfeil S; Böhm M; Lütjohann D; Weingärtner O
    Pharmacol Res Perspect; 2021 Aug; 9(4):e00801. PubMed ID: 34128357
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Diversity of Plant Sterols Metabolism: The Impact on Human Health, Sport, and Accumulation of Contaminating Sterols.
    Kopylov AT; Malsagova KA; Stepanov AA; Kaysheva AL
    Nutrients; 2021 May; 13(5):. PubMed ID: 34066075
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Low serum lathosterol levels associate with fatal cardiovascular disease and excess all-cause mortality: a prospective cohort study.
    Weingärtner O; Lütjohann D; Meyer S; Fuhrmann A; Cremers B; Seiler-Mußler S; Schött HF; Kerksiek A; Friedrichs S; Ulbricht U; Zawada A; Laufs U; Schulze PC; Scheller B; Fliser D; Böhm M; Sijbrands E; Heine GH
    Clin Res Cardiol; 2019 Dec; 108(12):1381-1385. PubMed ID: 30949753
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Association of Continuation of Statin Therapy Initiated Before Transition to Chronic Dialysis Therapy With Mortality After Dialysis Initiation.
    Streja E; Gosmanova EO; Molnar MZ; Soohoo M; Moradi H; Potukuchi PK; Kalantar-Zadeh K; Kovesdy CP
    JAMA Netw Open; 2018 Oct; 1(6):e182311. PubMed ID: 30646217
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Progress and perspectives in plant sterol and plant stanol research.
    Jones PJH; Shamloo M; MacKay DS; Rideout TC; Myrie SB; Plat J; Roullet JB; Baer DJ; Calkins KL; Davis HR; Barton Duell P; Ginsberg H; Gylling H; Jenkins D; Lütjohann D; Moghadasian M; Moreau RA; Mymin D; Ostlund RE; Ras RT; Ochoa Reparaz J; Trautwein EA; Turley S; Vanmierlo T; Weingärtner O
    Nutr Rev; 2018 Oct; 76(10):725-746. PubMed ID: 30101294
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Low-density lipoprotein cholesterol targeting with pitavastatin + ezetimibe for patients with acute coronary syndrome and dyslipidaemia: the HIJ-PROPER study, a prospective, open-label, randomized trial.
    Hagiwara N; Kawada-Watanabe E; Koyanagi R; Arashi H; Yamaguchi J; Nakao K; Tobaru T; Tanaka H; Oka T; Endoh Y; Saito K; Uchida T; Matsui K; Ogawa H
    Eur Heart J; 2017 Aug; 38(29):2264-2276. PubMed ID: 28430910
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ezetimibe: an update on its clinical usefulness in specific patient groups.
    Hammersley D; Signy M
    Ther Adv Chronic Dis; 2017 Jan; 8(1):4-11. PubMed ID: 28203346
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Enhanced Impact of Cholesterol Absorption Marker on New Atherosclerotic Lesion Progression After Coronary Intervention During Statin Therapy.
    Mori K; Ishida T; Tsuda S; Oshita T; Shinohara M; Hara T; Irino Y; Toh R; Hirata KI
    J Atheroscler Thromb; 2017 Feb; 24(2):123-132. PubMed ID: 27487947
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of Statin versus the Combination of Ezetimibe plus Statin on Serum Lipid Absorption Markers in Patients with Acute Coronary Syndrome.
    Watanabe E; Yamaguchi J; Arashi H; Ogawa H; Hagiwara N
    J Lipids; 2015; 2015():109158. PubMed ID: 25815213
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cholesterol metabolism and weight reduction in subjects with mild obstructive sleep apnoea: a randomised, controlled study.
    Hallikainen M; Tuomilehto H; Martikainen T; Vanninen E; Seppä J; Kokkarinen J; Randell J; Gylling H
    Cholesterol; 2013; 2013():769457. PubMed ID: 23762545
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The ABCG8 G574R variant, serum plant sterol levels, and cardiovascular disease risk in the Old Order Amish.
    Horenstein RB; Mitchell BD; Post WS; Lütjohann D; von Bergmann K; Ryan KA; Terrin M; Shuldiner AR; Steinle NI
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):413-9. PubMed ID: 23241408
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The "Mevalonate hypothesis": a cholesterol-independent alternative for the etiology of atherosclerosis.
    Keizer HG
    Lipids Health Dis; 2012 Nov; 11():149. PubMed ID: 23122424
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Lipid-lowering and anti-inflammatory effect of ezetimibe in hyperlipidemic patients with coronary artery disease.
    Tobaru T; Seki A; Asano R; Sumiyoshi T; Hagiwara N
    Heart Vessels; 2013 Jan; 28(1):39-45. PubMed ID: 22427252
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The associations of cholesterol metabolism and plasma plant sterols with all-cause and cardiovascular mortality.
    Silbernagel G; Fauler G; Hoffmann MM; Lütjohann D; Winkelmann BR; Boehm BO; März W
    J Lipid Res; 2010 Aug; 51(8):2384-93. PubMed ID: 20228406
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Indices of cholesterol metabolism and relative responsiveness to ezetimibe and simvastatin.
    Lakoski SG; Xu F; Vega GL; Grundy SM; Chandalia M; Lam C; Lowe RS; Stepanavage ME; Musliner TA; Cohen JC; Hobbs HH
    J Clin Endocrinol Metab; 2010 Feb; 95(2):800-9. PubMed ID: 19965915
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Baseline cholesterol absorption and the response to ezetimibe/simvastatin therapy: a post-hoc analysis of the ENHANCE trial.
    Jakulj L; Vissers MN; Groen AK; Hutten BA; Lutjohann D; Veltri EP; Kastelein JJ
    J Lipid Res; 2010 Apr; 51(4):755-62. PubMed ID: 19828909
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Genetic variation at the NPC1L1 gene locus, plasma lipoproteins, and heart disease risk in the elderly.
    Polisecki E; Peter I; Simon JS; Hegele RA; Robertson M; Ford I; Shepherd J; Packard C; Jukema JW; de Craen AJ; Westendorp RG; Buckley BM; Schaefer EJ;
    J Lipid Res; 2010 May; 51(5):1201-7. PubMed ID: 19752398
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cholesterol absorption and synthesis markers in individuals with and without a CHD event during pravastatin therapy: insights from the PROSPER trial.
    Matthan NR; Resteghini N; Robertson M; Ford I; Shepherd J; Packard C; Buckley BM; Jukema JW; Lichtenstein AH; Schaefer EJ;
    J Lipid Res; 2010 Jan; 51(1):202-9. PubMed ID: 19578163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.